Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 13 de 13
Filter
1.
Ann Pharm Fr ; 81(1): 123-137, 2023 Jan.
Article in French | MEDLINE | ID: mdl-35944697

ABSTRACT

OBJECTIVES: While inhaled drugs are mainly used to treat chronic respiratory diseases, they are also responsible for greenhouse gas (GHG) emission. To highlight this issue, a dispensed analysis and a carbon footprint evaluation of inhalers in France have been conducted. METHODS: A national qualitative and quantitative analysis of dispensed inhalers in community pharmacies (CP) and hospitals (H) was conducted in France for 2019. A data review from the literature led to the determination of the inhalers carbon footprint, expressed in carbon dioxide equivalent (CO2e) during the inhaler life cycle. RESULTS: Close to 40 million inhalers were dispensed by community pharmacies and one million by hospitals in 2019. It concerned three types of inhalers: metered-dose inhalers (MDI) [CP: 49%; H: 45%], dry powder inhalers (DPI) [CP: 47%; H: 51%], and soft mist inhalers (SMI) [CP: 4%; H: 4%]. According to the literature, MDI have the highest carbon footprint, ranging from 11 to 28 kgCO2e versus less than 1 kgCO2e for DPI/SMI. In 2019, the national carbon footprint of salbutamol (MDI), the most dispensed inhaler, was estimated to be over 310 million kgCO2e (CP+H) corresponding to more than 310,000 round-trip Paris-New York. CONCLUSIONS: This study shows the involvement of MDI in GHG emissions. Taking actions as part of a global and coordinated approach to limit their environmental impact is possible and thus is a priority.


Subject(s)
Dry Powder Inhalers , Metered Dose Inhalers , Administration, Inhalation , Albuterol , Carbon Footprint
2.
Curr Res Microb Sci ; 3: 100100, 2022.
Article in English | MEDLINE | ID: mdl-35005659

ABSTRACT

BACKGROUND: Nanoarchaeota, obligate symbiont of some environmental archaea with reduced genomes, have been described in marine thermal vent environments, yet never detected in hosts, including humans. METHODS: Here, using laboratory tools geared towards the detection of nanoarchaea including PCR-sequencing, WGS, microscopy and culture. RESULTS: We discovered a novel nanoarchaea, Nanopusillus massiliensis, detected in dental plate samples by specific PCR-based assays. Combining fluorescent in situ hybridization (FISH) with scanning electron microscopy disclosed close contacts between N. massiliensis and the archaea Methanobrevibacter oralis in these samples. Culturing one sample yielded co-isolation of M. oralis and N. massiliensis with a 606,935-bp genome, with 23.6% GC encoded 16 tRNA, 3 rRNA and 942 coding DNA sequences, of which 400 were assigned to clusters of orthologous groups. CONCLUSION: The discovery of N. massiliensis, made publicly available in collection, extended our knowledge of human microbiota diversity, opening a new field of research in clinical microbiology here referred to as clinical nanoarchaeology.

3.
Ann Pharm Fr ; 80(2): 216-226, 2022 Mar.
Article in French | MEDLINE | ID: mdl-34153241

ABSTRACT

OBJECTIVES: Healthcare products (HP) have a significant carbon footprint that must be included by regulation in the facility's purchasing policy. A national overview of the inclusion of environmental criteria (EC) in the public procurement (PP) of HP in hospitals has been carried out. METHODS: Thirty EC were identified in the literature. Two questionnaires were proposed: (i) for buyers that analyze the level of "importance" and "ease of application" for public tenders (PT), and (ii) for suppliers that declare their commitments and evidence. RESULTS: Six regional buyers and 28 suppliers participated. Buyers recognize the "importance" of sustainable development (SD) but are more reticent about the "applicability" of EC in PT. The environmental rating remains low: on average 4.38 (0.25-10.00) % of the total rating. Only 12 EC are integrated within some PT. Suppliers report a high and diversified commitment to SD: 18 suppliers sent 474 evidence. Buyers and suppliers converge on the optimization of primary packaging and the establishment of a minimum order or delivery group. CONCLUSIONS: Since the efficiency of PP is inevitable, EC that combines SD and savings should be prioritized. The integration of additional EC, simple and easily documented, allowing cost containment for both suppliers and buyers, is possible to promote sustainable purchasing.


Subject(s)
Carbon Footprint , Drug Costs , Equipment and Supplies , Cost Control , Equipment and Supplies/economics , France , Humans
4.
Rev Mal Respir ; 37(9): 743-747, 2020 Nov.
Article in French | MEDLINE | ID: mdl-32868166

ABSTRACT

INTRODUCTION: Sclerosing pneumocytoma is a benign and rare lung tumor affecting epithelial cells. In most cases, patients are asymptomatic and the diagnosis is made on an X ray or a CT scan performed for other enquiry. Sex ratio favors women. Epidemiological studies report that middle-aged Asian women are more frequently affected. Radiological investigations find a solitary nodule or a mass with peripheric localization. When performed, histological analysis shows a tumor composed of at least two of the four following architectures: papillary, sclerosing, hemangiomatous and solid, with two types of cells that can be round or cubic cells. CASES REPORT: We report two cases of multiple sclerosing pneumocytoma in two caucasien men. The first patient was asymptomatic, the second complain from moderate dyspnea. A wedge resection was performed in both, allowing diagnosis. Anatomopathology revealed respectively a predominant sclerosing and solid architecture and a sclerosing and papillary architecture. There was no progression of the other concomitant nodules after three years follow-up. CONCLUSION: Pneumocytoma is a benign, slow-growing tumor with good prognosis.


Subject(s)
Lung Neoplasms/pathology , Lung Neoplasms/surgery , Pulmonary Sclerosing Hemangioma/pathology , Pulmonary Sclerosing Hemangioma/surgery , Disease Progression , Humans , Lung Neoplasms/diagnosis , Male , Middle Aged , Neoplasm Staging , Pneumonectomy , Prognosis , Pulmonary Sclerosing Hemangioma/diagnosis , Radiography, Thoracic , Rare Diseases
5.
New Microbes New Infect ; 36: 100687, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32528685

ABSTRACT

Strain Marseille-P9525T is a Gram-positive, obligatory anaerobic and non-motile bacterium isolated from a human faecal micobiota. Its phenotypic pattern, including mass spectrometry peptide profile and genome sequence, support the proposal of a new species for which the name Enorma burkinafasonensis sp. nov. is proposed. The type strain has been deposited in a public collection.

6.
New Microbes New Infect ; 36: 100702, 2020 Jul.
Article in English | MEDLINE | ID: mdl-32528688

ABSTRACT

Strain Marseille-Q0835T is an aerobic, non-motile and non-spore-forming Gram-positive coccus isolated from the stools of a Burkinabe woman. In this report, we present its phenotypic description including MALDI-TOF mass spectrometry analysis and genome sequencing. Strain Marseille-Q0835T; 2.9768-Mb genome exhibited a 41.9 mol% G+C content and 2699 predicted genes. Considering phenotypic features and comparative genome studies, we propose the strain Marseille-Q0835T as the type strain of Enterococcus burkinafasonensis sp. nov., a new species within the family Enterococcaceae.

7.
Neurosurg Rev ; 41(1): 125-132, 2018 Jan.
Article in English | MEDLINE | ID: mdl-28799142

ABSTRACT

Hemispherotomy is an established surgical technique to cure or palliate selected, mostly young patients suffering from refractory epilepsy. However, a few patients continue to have seizures despite the surgical hemispherical disconnection. We present a case series of patients who underwent redo hemispherotomy after a first unsuccessful hemispherical disconnection and provide a roadmap for subsequent workup and treatment. The institutional database of epilepsy surgery was reviewed. Twenty-four patients who underwent hemispherotomies for refractory epilepsy were identified between 2007 and 2016. Patients' notes were checked for demographics, history, clinical presentation, preoperative workup, medical treatment, age at first hemispherotomy, and surgical technique. Complications, histopathology, postoperative antiepileptic drug, and postoperative neurological follow-up were documented. Engel class was used to determine the outcome after surgery. Three patients (one hemimegalencephaly, one perinatal stroke, and one Rasmussen's disease) underwent redo hemispherotomy after electroencephalography and MRI studies with particular importance given to diffusion tensor imaging (DTI) to demonstrate residual connection between hemispheres. In one case, redo disconnection followed by a frontal lobectomy rendered the patient seizure-free (Engel class I). In one case, the seizure frequency remained the same but generalized seizures disappeared (Engel class III), and in one case, seizure frequency was considerably reduced after the redo disconnection (Engel class II), with a minimum follow-up of 2 years. Surgical aspects, possible reasons of failure of first hemispherotomy, and rationale that led to second-look surgery are presented. Reasons for failure can be related to patient's selection and/or surgical aspects. Hemispherotomy is a technically demanding procedure and requires accurate preoperative workup. Redo hemispherotomy is a valid option on the basis of further epileptological and radiological workup to demonstrate residual interhemispheric connections and/or rule out bi-hemispheric epileptic activity.


Subject(s)
Drug Resistant Epilepsy/surgery , Hemispherectomy , Seizures/prevention & control , Adolescent , Adult , Anticonvulsants/therapeutic use , Child , Child, Preschool , Cohort Studies , Diffusion Tensor Imaging , Drug Resistant Epilepsy/diagnostic imaging , Electroencephalography , Female , Humans , Infant , Infant, Newborn , Magnetic Resonance Imaging , Male , Reoperation , Seizures/diagnosis , Seizures/etiology , Treatment Outcome , Young Adult
8.
Inhal Toxicol ; 25(7): 373-82, 2013 Jun.
Article in English | MEDLINE | ID: mdl-23796016

ABSTRACT

INTRODUCTION: Benzene is a ubiquitous pollutant of both indoor and outdoor environments which impacts on respiratory health. Our aim was to relate urinary S-phenylmercapturic acid (S-PMA), a biomarker of benzene exposure, to benzene concentrations and related sources at home and asthma in a population-based sample of children. METHODS: Exposure to benzene was assessed in the dwellings of 63 children (32 asthmatics and 31 controls) through the identification of sources of benzene and in situ assessments with passive samplers. The determination of urinary S-PMA was obtained by liquid chromatography-mass spectrometry. RESULTS: At home, asthmatics were significantly more polluted by benzene levels from ambient sampling than controls (p ≤ 0.05). Benzene exposure significantly aggravated asthma symptoms overall in non-atopic children (OR = 10.10; 95% confidence interval: 10.10). Urinary S-PMA was significantly associated with benzene concentrations in the entire population (regression coefficient = 0.28, 95% CI: 0.07-0.49; p < 0.05) and asthma (OR = 7.69; 95% CI: 1.37-42.52 for an increase of 1 µg/g creatinine of urinary S-PMA). However, after adjustment for environmental tobacco smoking exposure, familial allergy, age and sex, the latter relationship was no more significant (OR = 4.95; 95% CI: 0.91-27.4, p < 0.10). Both benzene concentrations and urinary S-PMA concentrations were higher in dwelling built after 1948 and in flats. CONCLUSIONS: Our study suggests a relationship between childhood asthma and benzene concentrations at home, even at low levels of this pollutant. This was confirmed when considering urinary S-PMA, which was related to both benzene concentrations and asthma. Further epidemiological and toxicological studies are needed to confirm our results.


Subject(s)
Acetylcysteine/analogs & derivatives , Air Pollutants/analysis , Air Pollution, Indoor/analysis , Asthma/epidemiology , Benzene/analysis , Acetylcysteine/urine , Adolescent , Asthma/urine , Biomarkers/urine , Case-Control Studies , Child , Environmental Monitoring , Female , France/epidemiology , Housing , Humans , Inhalation Exposure/adverse effects , Inhalation Exposure/analysis , Male
9.
Chir Main ; 32(2): 117-9, 2013 Apr.
Article in French | MEDLINE | ID: mdl-23490214

ABSTRACT

Trichilemmal cyst is a benign tumor, developed from hair follicle, located mainly at the scalp. We report a clinical case of unusual location at the finger pulp confirmed by histology. The main differential diagnosis in this reported case was a whitlow. The origin of this cyst is probably the nail matrix whose keratinization is trichilemmal. Surgical excision biopsy allowed a good clinical outcome.


Subject(s)
Fingers/surgery , Follicular Cyst/pathology , Hair Diseases/pathology , Adult , Diagnosis, Differential , Epidermal Cyst , Follicular Cyst/surgery , Hair Diseases/surgery , Humans , Male
10.
Eur Ann Otorhinolaryngol Head Neck Dis ; 129(5): 264-71, 2012 Oct.
Article in English | MEDLINE | ID: mdl-23078979

ABSTRACT

OBJECTIVE: This article presents the Clinical Practice Guidelines for Pediatric Tonsillectomy of the French Society of ENT and Head and Neck Surgery (SFORL), entitled "Amygdalectomie de l'enfant : Recommandation pour la pratique clinique" (SFORL, 2009). METHOD: The French Society of ENT (SFORL), in partnership with the French Association for Ambulatory Surgery (AFCA) and French Society for Anaesthesia and Intensive Care (SFAR), set up a representative panel in the fields of anesthesiology, ENT and head-and-neck surgery, pediatrics, sleep medicine and general medicine. Following the literature analysis reported in the Presentation of the Guidelines, recommendations were drawn up taking account of risk/benefit ratios, levels of evidence, feasibility in pediatric tonsillectomy and baseline risk assessment in the relevant population. RESULTS: Around 50,000 pediatric tonsillectomies, with or without associated adenoidectomy, are performed in France each year. Postoperative morbidity and mortality are non-negligible, despite progress in peri-operative management. The present guidelines address the following questions: 1) What are the indications for tonsillectomy, notably in case of obstructive sleep disorder; 2) What pre-operative assessment is required? 3) What are the technical principles involved? 4) What are the selection criteria for ambulatory tonsillectomy? 5) How should postoperative follow-up be organized? 6) How should complications be managed? CONCLUSION: The present Clinical Practice Guidelines for pediatric tonsillectomy in France should improve clinical and organizational practices to enhance patient safety. They seek to ensure optimal conditions of care for all children undergoing tonsillectomy.


Subject(s)
Sleep Apnea, Obstructive/surgery , Tonsillectomy , Child , Chronic Disease , France , Humans , Otorhinolaryngologic Surgical Procedures/methods , Risk Assessment , Risk Factors , Sleep Apnea, Obstructive/etiology , Societies, Medical , Tonsillectomy/methods , Tonsillitis/complications , Tonsillitis/pathology , Tonsillitis/surgery , Treatment Outcome
11.
Bull Cancer ; 96(5): 579-89, 2009 May.
Article in French | MEDLINE | ID: mdl-19467988

ABSTRACT

Malignant gliomas are the most frequent primary brain tumors in adults. Temozolomide is an oral alkylating cytotoxic agent of second generation, used in the treatment of high-grade gliomas. It is indicated in newly diagnosed glioblastoma multiform as well as in recurrent or progressive malignant gliomas, such as glioblastoma multiform or anaplastic astrocytoma. However, temozolomide is also used, off label, in other clinical situations and the main objective of this study was to establish recommendations and guidelines for relevant prescriptions of temozolomide in primary brain tumors and brain metastasis in adults. The literature review was analysed by experts who determined the evidence level (A to E) according to the scale of recommendations adopted by the "Haute Autorité de santé--HAS--(French National Authority for Health)". For high-grade and low-grade gliomas, based on the level of evidence from the literature, the use of temozolomide can be justified, with a B2 score attributed to these indications. In contrast, for the others indications, the use of temozolomide appeared to be more controversial or even not recommended (score C to E). Regarding the dosing schedule and administration scheme, as well as the co-administration with other anticancer drugs, a C score was attributed for the off label situations.


Subject(s)
Antineoplastic Agents, Alkylating/therapeutic use , Brain Neoplasms/drug therapy , Dacarbazine/analogs & derivatives , Glioma/drug therapy , Age Factors , Antineoplastic Agents, Alkylating/administration & dosage , Astrocytoma/drug therapy , Brain Neoplasms/secondary , Dacarbazine/administration & dosage , Dacarbazine/therapeutic use , Drug Administration Schedule , Drug Labeling , Glioblastoma/drug therapy , Humans , Temozolomide
13.
Ann Otolaryngol Chir Cervicofac ; 107(8): 521-5, 1990.
Article in French | MEDLINE | ID: mdl-2085253

ABSTRACT

Of a series of 23 patients presenting sudden deafness, treatment by normovolemic hemodilution yielded good results in 17 cases (74%), including 14 excellent results (61%) with constant efficacy on the tinnitus aurium (100%). These results appear overall superior to the 40 to 65% improvements reported in the literature. Nevertheless, comparisons in this area must take into account the very different assessment criteria applied from one series to another. The authors propose using the formula established to assess professional deafness, but taking the other ear as a reference.


Subject(s)
Hearing Loss, Sudden/therapy , Hemodilution , Adult , Aged , Audiometry , Evaluation Studies as Topic , Humans , Middle Aged , Time Factors , Tinnitus/etiology
SELECTION OF CITATIONS
SEARCH DETAIL
...